CEPI will provide funding of up to US $19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine candidate to an international multidisciplinary consortium
The FDA has determined that the known and potential benefits of the vaccine for the prevention of Covid-19 outweigh the known and potential risks for individuals 18 years of age and older for whom other authorized or approved vaccines are not accessible
Demand for pharmacies contribute to 52% of the total searches, vaccination centres 30%
The report has estimated 4.74 million deaths for India in 2020 and 2021,
Submission to regulators globally is based on phase 2/3 studies of mRNA-1273 in young children
University of Pennsylvania scientists Katalin Karikó and Drew Weissman to be honoured at June 7 symposium in New York City for their research that enabled Covid-19 vaccines
This action makes Veklury the first approved Covid-19 treatment for children less than 12 years of age
Real-world evidence from more than 850,000 hospitalized patients provides clinical insights on the use of Veklury (remdesivir) as stand of care Covid-19 treatment
A separate global Phase 3 study of S-217622 is underway aiming to recruit participants globally to support regulatory filings this year
Kaiser Permanente finds the Pfizer Covid-19 third dose vaccine protection against hospitalization from omicron wanes after 3 months
Subscribe To Our Newsletter & Stay Updated
